GB9325827D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB9325827D0
GB9325827D0 GB939325827A GB9325827A GB9325827D0 GB 9325827 D0 GB9325827 D0 GB 9325827D0 GB 939325827 A GB939325827 A GB 939325827A GB 9325827 A GB9325827 A GB 9325827A GB 9325827 D0 GB9325827 D0 GB 9325827D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939325827A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB939325827A priority Critical patent/GB9325827D0/en
Publication of GB9325827D0 publication Critical patent/GB9325827D0/en
Priority to ZA9410004A priority patent/ZA9410004B/en
Priority to EP95904482A priority patent/EP0734378A1/en
Priority to AU13149/95A priority patent/AU1314995A/en
Priority to PCT/EP1994/004175 priority patent/WO1995016674A1/en
Priority to JP7516539A priority patent/JPH09507472A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB939325827A 1993-12-17 1993-12-17 Compounds Pending GB9325827D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB939325827A GB9325827D0 (en) 1993-12-17 1993-12-17 Compounds
ZA9410004A ZA9410004B (en) 1993-12-17 1994-12-15 Aminosulphonyl-phenyl-1h-pyrrole derivatives method of their preparation and their use
EP95904482A EP0734378A1 (en) 1993-12-17 1994-12-16 Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
AU13149/95A AU1314995A (en) 1993-12-17 1994-12-16 Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
PCT/EP1994/004175 WO1995016674A1 (en) 1993-12-17 1994-12-16 Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
JP7516539A JPH09507472A (en) 1993-12-17 1994-12-16 Aminosulfonyl-phenyl-1H-pyrrole derivatives, process for their preparation and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939325827A GB9325827D0 (en) 1993-12-17 1993-12-17 Compounds

Publications (1)

Publication Number Publication Date
GB9325827D0 true GB9325827D0 (en) 1994-02-23

Family

ID=10746764

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939325827A Pending GB9325827D0 (en) 1993-12-17 1993-12-17 Compounds

Country Status (6)

Country Link
EP (1) EP0734378A1 (en)
JP (1) JPH09507472A (en)
AU (1) AU1314995A (en)
GB (1) GB9325827D0 (en)
WO (1) WO1995016674A1 (en)
ZA (1) ZA9410004B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0922035B1 (en) * 1996-08-14 2001-02-07 Smithkline Beecham Plc Tetrahydroisoquinoline derivatives and their pharmaceutical use
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
NZ501258A (en) * 1997-07-11 2001-07-27 Smithkline Beecham P Benzenesulfonamide compounds with 5HT6 receptor antagonist activity for treating anxiety and/or depression
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
CA2346689A1 (en) 1998-10-08 2000-04-20 Gregor James Macdonald Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
DE19963174A1 (en) 1999-12-27 2001-07-12 Gruenenthal Gmbh Substituted pyrrole Mannich bases
EP1922068A4 (en) * 2005-08-16 2010-08-11 Icagen Inc Inhibitors of voltage-gated sodium channels
WO2007091140A1 (en) * 2006-02-06 2007-08-16 Pfizer Products Inc. Substituted phenylsulfamoyl compounds as ppar agonists
EP2297134A1 (en) * 2008-05-21 2011-03-23 Basf Se Substituted pyridin-4 -yl-methyl sulfonamides as fungicides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2835438A1 (en) * 1978-08-12 1980-03-06 Basf Ag AMINOPROPANOL DERIVATIVES OF 2- (O-HYDROXYPHENYL) PYRROL
DE2835439A1 (en) * 1978-08-12 1980-02-28 Basf Ag 2- (O-HYDROXYPHENYL) -PYRROL
IL81669A (en) * 1986-02-27 1990-11-29 Duphar Int Res Aryl-substituted(n-piperidinyl)methyl-and(n-piperazinyl)-methylazoles,their preparation and pharmaceutical compositions containing them
US5523299A (en) * 1992-08-06 1996-06-04 Smithkline Beecham Plc 5-(2-oxyphenyl)-pyrrole derivatives as dopamine D3 receptor antagonists

Also Published As

Publication number Publication date
EP0734378A1 (en) 1996-10-02
JPH09507472A (en) 1997-07-29
AU1314995A (en) 1995-07-03
WO1995016674A1 (en) 1995-06-22
ZA9410004B (en) 1995-10-27

Similar Documents

Publication Publication Date Title
GB9304620D0 (en) Compounds
GB9310978D0 (en) Compounds
GB9302016D0 (en) Compounds
GB9325827D0 (en) Compounds
GB9315801D0 (en) Compounds
GB9307400D0 (en) Compounds
GB9320855D0 (en) Compounds
GB9315800D0 (en) Compounds
GB9317314D0 (en) Compounds
EP0733044A4 (en) Compounds
GB9322818D0 (en) Compounds
GB9320214D0 (en) Compounds
GB9302636D0 (en) Compounds
GB9302621D0 (en) Organiz compounds
GB9320617D0 (en) Compounds
GB9321150D0 (en) Compounds
GB9318380D0 (en) Compounds
GB9302027D0 (en) Compounds
GB9300090D0 (en) Compounds
GB9300088D0 (en) Compounds
GB9321151D0 (en) Compounds
GB9309618D0 (en) Compounds
GB9309620D0 (en) Compounds
GB9320186D0 (en) Compounds
GB9320616D0 (en) Compounds